Abstract
AbstractA novel series of 4‐arylthio‐ or 4‐arylsulfonyl‐substituted 2‐amino‐5,6,7,8‐tetrahydroquiazolines was synthesized and evaluated for serotonin receptor subtype 6 (5‐HT6R) antagonistic effects in vitro. The structure activity relationships (SAR) of this series were discussed on the basis of in vitro activity. Among the derivatives synthesized in the present study, the lead compound, 7a, having sulfonyl functionality at the 4‐position and N‐methylpiperazine at the 2‐position of the core structure showed the most potent 5‐HT6 receptor inhibitory activity in vitro and good metabolic stability without CYP liability.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
